ArticleEMBO molecular medicine2014

Inflammatory monocytes promote progression of Duchenne muscular dystrophy and can be therapeutically targeted via CCR2.

Kamalika Mojumdar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.